Estrogen Receptor Beta (ERβ): A Ligand Activated Tumor SuppressorRahul Mal, Mathew Cherian, Alexa Magner et al.|Frontiers in Oncology|2020Cited by 127
Progression-Free Survival for Real-World Use of Palbociclib in Hormone Receptor-Positive Metastatic Breast CancerJonathan Wilkie, Craig Vargo, M. Alexandra Schickli et al.|Clinical Breast Cancer|2019Cited by 47
Worry and rumination in breast cancer patients: perseveration worsens self-rated healthMegan E. Renna, Janice K. Kiecolt‐Glaser, M. Rosie Shrout et al.|Journal of Behavioral Medicine|2020Cited by 41
Clinical impact of interruption in adjuvant Trastuzumab therapy in patients with operable HER-2 positive breast cancerSagar Sardesai, Bhuvaneswari Ramaswamy, Jasmine Sukumar et al.|Cardio-Oncology|2020Cited by 32
Assessment of outcomes and novel immune biomarkers in metaplastic breast cancer: a single institution retrospective studyEvan Morgan, Maryam B. Lustberg, Anupama Suresh et al.|World Journal of Surgical Oncology|2020Cited by 31